[1] Russo FP, Rodríguez-Castro K, Scribano L, et al.Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease. World J Hepatol, 2015, 7:1097-1104.
[2] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南.肝脏, 2015, 20: 915-932.
[3] Tangeras LH, Stødle GS, Olsen GD, et al. Functional Toll-like receptors in primary first-trimester trophoblasts. J Reprod Immunol, 2014, 106: 89-99.
[4] Shi X, Jiao B, Chen Y, et al. MxA is a positive regulator of type I IFN signaling in HCV infection. J Med Virol, 2017, 89: 2173-2180.
[5] Zhang H, Guan ZS, Guan SH, et al. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro. Clin Lab, 2016, 62:2313-2318.
[6] Chandra PK, Gunduz F, Hazari S, et al. Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. PLoS One, 2014, 9: e108616.
[7] Vanwolleghem T, Hou J, van Oord G, et al. Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells. Hepatology, 2015, 62:87-100. .
[8] Tian Y, Chen WL, Ou JH. Effects of interferon-alpha/beta on HBV replication determined by viral load. PLoS Pathog, 2011, 7:e1002159. .
[9] Cui X, Clark DN, Liu K, Xu XD, Guo JT, Hu J. Viral DNA-Dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes. J Virol, 2015, 90:486-496.
[10] Sato S, Li K, Kameyama T, et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity, 2015, 42:123-132.
[11] Momeni M, Zainodini N, Bidaki R, et al. Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients. Hum Immunol, 2014, 75:15-19. .
[12] Ebrahim M, Mirzaei V, Bidaki R, et al. Are RIG-1 and MDA5 Expressions Associated with Chronic HBV Infection? Viral Immunol, 2015, 28:504-508. |
